List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 7 studies with search of:   "Italfarmaco" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Phase II High Pulse Dose Clinical Trial of Orally Administered ITF2357 In Patients With Relapsed/Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: ITF2357
2 Recruiting Phase IIA Study of the HDAC Inhibitor ITF2357 in Patients With JAK-2 V617F Positive Chronic Myeloproliferative Diseases
Condition: Myeloproliferative Diseases
Intervention: Drug: ITF2357
3 Recruiting phII Study of an HDAC Inhibitor in Very High-Risk Relapsed/Refractory Hodgkin's Lymphoma Patients
Condition: Hodgkin's Lymphoma
Intervention: Drug: histone deacetylase inhibitor (ITF2357)
4 Recruiting Phase II Study of Histone-Deacetylase Inhibitor ITF2357 in Refractory/Relapsed Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: ITF2357
5 Terminated Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of ITF2357 on Mucosal Healing in Patients With Moderate-to-Severe Active Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: ITF2357;   Drug: Placebo capsules
6 Completed Phase II, Open Label, International, Multicentre Clinical Trial to Investigate Safety and Efficacy of Oral ITF2357 in Patients With Active Systemic Onset Juvenile Idiopathic Arthritis (SOJIA)
Conditions: Active Systemic;   Onset Juvenile Idiopathic Arthritis
Intervention: Drug: ITF2357
7 Recruiting Phase II Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma Patients
Condition: Hodgkin's Lymphoma
Intervention: Drug: ITF2357

  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services